tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Amsellem, 284 are a BUY (70.3%), 107 are a HOLD (26.49%), 13 are a SELL (3.22%).
Analyst David Amsellem, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 55.77% that have a potential upside of 31.73% achieved within 211 days.
David Amsellem’s has documented 805 price targets and ratings displayed on 47 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMGN, Amgen at 19-Feb-2026.
Analyst best performing recommendations are on RVNC (REVANCE THE).
The best stock recommendation documented was for RVNC (REVANCE THE) at 8/9/2024. The price target of $6 was fulfilled within 3 days with a profit of $2.47 (69.97%) receiving and performance score of 233.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 17-Nov-2021
$12.5
4 years 3 months 10 days ago
(17-Nov-2021)
0/3 (0%)
$7.13 (132.77%)
Hold Since 13-Oct-2021
$8
$-0.22 (-2.68%)
$7
4 years 4 months 14 days ago
(13-Oct-2021)
4/8 (50%)
$-0.07 (-0.87%)
95
Hold Since 13-Oct-2021
$14
4 years 4 months 14 days ago
(13-Oct-2021)
3/7 (42.86%)
$9.25 (194.74%)
87
Hold Since 13-Oct-2021
$12
4 years 4 months 14 days ago
(13-Oct-2021)
0/6 (0%)
$7 (140.00%)
Buy
$6
$-2.22 (-27.01%)
$20
4 years 4 months 14 days ago
(12-Oct-2021)
0/2 (0%)
$3.2 (23.94%)
Which stock is David Amsellem is most bullish on?
Which stock is David Amsellem is most reserved on?
What Year was the first public recommendation made by David Amsellem?
